Bronstein Ben 4
4 · Aldeyra Therapeutics, Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-08+875→ 875 totalExercise: $12.97Exp: 2031-06-07→ Common Stock (875 underlying) - Award
Stock Option (Right to Buy)
2021-06-08+933→ 933 totalExercise: $12.97Exp: 2031-06-07→ Common Stock (933 underlying) - Award
Stock Option (Right to Buy)
2021-06-08+13,534→ 13,534 totalExercise: $12.97Exp: 2031-06-07→ Common Stock (13,534 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.